Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lawn

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
JAMA Neurology|August 29, 2022
Development and Validation of a Deep Learning Model for Predicting Treatment Response in Patients With Newly Diagnosed EpilepsyHaris Hakeem, Wei Feng, Zhibin Chen, et al.
BMJ Open|December 5, 2024
RESILIENCE (Retrospective Linkage Study of Autoimmune Encephalitis): protocol for an Australian retrospective cohort study of outcomes in autoimmune encephalitis using data linkage techniquesAmy Jean Halliday, Katrina Lambert, Christine Bundell, et al.
BMJ Open|October 27, 2023
Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocolLucy Vivash, Hannah Johns, Leonid Churilov, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
JAMA Neurology|August 29, 2022
Development and Validation of a Deep Learning Model for Predicting Treatment Response in Patients With Newly Diagnosed EpilepsyHaris Hakeem, Wei Feng, Zhibin Chen, et al.
BMJ Open|December 5, 2024
RESILIENCE (Retrospective Linkage Study of Autoimmune Encephalitis): protocol for an Australian retrospective cohort study of outcomes in autoimmune encephalitis using data linkage techniquesAmy Jean Halliday, Katrina Lambert, Christine Bundell, et al.
BMJ Open|October 27, 2023
Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocolLucy Vivash, Hannah Johns, Leonid Churilov, et al.
Pageof 4